15 results on '"Bharatham, B. Hemabarathy"'
Search Results
2. Vancomycin Loaded Alginate/Cockle Shell Powder Nanobiocomposite Bone Scaffold for Antibacterial and Drug Release Evaluation
3. Pre-mineralisation effect of nanobiocomposite bone scaffold towards bone marrow-derived stem cells growth and differentiation
4. A short review on cockle shells as biomaterials in the context of bone scaffold fabrication
5. PRE-MINERALISATION EFFECT OF NANOBIOCOMPOSITE BONE SCAFFOLD TOWARDS BONE MARROW-DERIVED STEM CELLS GROWTH AND DIFFERENTIATION
6. The Effect of DMEM and DMEM:F12 Culture Media on the Growth of SH-SY5Y Cells
7. Zerumbone alleviates neuropathic pain through the involvement of L-arginine-nitric oxide-cGMP-K+ ATP channel pathways in chronic constriction injury in mice model
8. Cardamonin attenuates hyperalgesia and allodynia in a mouse model of chronic constriction injury-induced neuropathic pain: Possible involvement of the opioid system
9. Cardamonin attenuates hyperalgesia and allodynia in a mouse model of chronic constriction injury-induced neuropathic pain: possible involvement of the opioid system
10. Antiallodynic and antihyperalgesic effects of zerumbone on a mouse model of chronic constriction injury-induced neuropathic pain
11. Development and characterization of novel porous 3D alginate-cockle shell powder nanobiocomposite bone scaffold
12. Cytotoxicity and Oxidative Stress Evaluation of Alginate/Cockle Shell Powder Nanobiocomposite Bone Scaffold on Osteoblast.
13. Development and Characterization of Novel Porous 3D Alginate-Cockle Shell Powder Nanobiocomposite Bone Scaffold
14. Development and evaluation of novel alginate/cockle shell powder nano-biocomposite porous 3D scaffold for bone repair
15. Zerumbone Alleviates Neuropathic Pain through the Involvement of l-Arginine-Nitric Oxide-cGMP-K⁺ ATP Channel Pathways in Chronic Constriction Injury in Mice Model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.